The MyHizentra™ App has been developed on behalf of CSL Behring (Australia) Pty Ltd ABN 48 160 734 761 (“CSL Behring”), 189–209 Camp Rd, Broadmeadows VIC 3047, Australia. This app is designed to be used only by Australian patients prescribed HIZENTRA®. An activation code is therefore required to access the app. Australian patients can contact their nurse or doctor to request an activation code. The app includes information about HIZENTRA® and a patient diary to record HIZENTRA® infusions, which includes barcode scanning/decoding and functionality to send a tabulated form of the diary to a patients nurse or doctor. Also provided is an infusion reminder service and functionality for a patient to record and manage their HIZENTRA® stock in the home. less
|